Literature DB >> 1446802

CD8 T cells are not required for islet destruction induced by a CD4+ islet-specific T-cell clone.

B J Bradley1, K Haskins, F G La Rosa, K J Lafferty.   

Abstract

A panel of CD4+ T-cell clones has been isolated from the spleen and lymph nodes of diabetic NOD mice. These clones have been shown to be islet-specific both in vivo and in vitro. One of the clones, BDC-6.9, initiates extensive damage to islet tissue when placed adjacent to an NOD islet graft that has been used to reverse diabetes in (CBA x NOD)F1 recipients or when injected intraperitoneally into such animals. In this study, we show that BDC-6.9 T cells can initiate islet destruction in the absence of detectable CD8 T cells either in the periphery or in the lesion that develops after the transfer of the cloned islet-reactive T cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1446802     DOI: 10.2337/diab.41.12.1603

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  11 in total

Review 1.  The role of interleukin-1 in the pathogenesis of IDDM.

Authors:  T Mandrup-Poulsen
Journal:  Diabetologia       Date:  1996-09       Impact factor: 10.122

Review 2.  Pathogenic mechanisms in type 1 diabetes: the islet is both target and driver of disease.

Authors:  Kate L Graham; Robyn M Sutherland; Stuart I Mannering; Yuxing Zhao; Jonathan Chee; Balasubramanian Krishnamurthy; Helen E Thomas; Andrew M Lew; Thomas W H Kay
Journal:  Rev Diabet Stud       Date:  2012-12-28

Review 3.  IDDM: an islet or an immune disease?

Authors:  C Boitard; E Larger; J Timsit; P Sempe; J F Bach
Journal:  Diabetologia       Date:  1994-09       Impact factor: 10.122

4.  Antigen-Specific T Cell Analysis Reveals That Active Immune Responses to β Cell Antigens Are Focused on a Unique Set of Epitopes.

Authors:  Junbao Yang; Xiaomin Wen; Hengyu Xu; Nadia Torres-Chinn; Cate Speake; Carla J Greenbaum; Gerald T Nepom; William W Kwok
Journal:  J Immunol       Date:  2017-05-26       Impact factor: 5.422

5.  Perforin-independent beta-cell destruction by diabetogenic CD8(+) T lymphocytes in transgenic nonobese diabetic mice.

Authors:  A Amrani; J Verdaguer; B Anderson; T Utsugi; S Bou; P Santamaria
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

6.  Type 1 diabetes development requires both CD4+ and CD8+ T cells and can be reversed by non-depleting antibodies targeting both T cell populations.

Authors:  Jenny M Phillips; Nicole M Parish; Tim Raine; Chris Bland; Yvonne Sawyer; Hugo De La Peña; Anne Cooke
Journal:  Rev Diabet Stud       Date:  2009-08-10

7.  Autoreactive T cells induce necrosis and not BCL-2-regulated or death receptor-mediated apoptosis or RIPK3-dependent necroptosis of transplanted islets in a mouse model of type 1 diabetes.

Authors:  Yuxing Zhao; Nicholas A Scott; Stacey Fynch; Lorraine Elkerbout; W Wei-Lynn Wong; Kylie D Mason; Andreas Strasser; David C Huang; Thomas W H Kay; Helen E Thomas
Journal:  Diabetologia       Date:  2014-10-10       Impact factor: 10.122

8.  Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-beta, and prostaglandin-E.

Authors:  W W Hancock; M Polanski; J Zhang; N Blogg; H L Weiner
Journal:  Am J Pathol       Date:  1995-11       Impact factor: 4.307

9.  Reduced incidence and delayed onset of diabetes in perforin-deficient nonobese diabetic mice.

Authors:  D Kägi; B Odermatt; P Seiler; R M Zinkernagel; T W Mak; H Hengartner
Journal:  J Exp Med       Date:  1997-10-06       Impact factor: 14.307

10.  Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice.

Authors:  J Verdaguer; D Schmidt; A Amrani; B Anderson; N Averill; P Santamaria
Journal:  J Exp Med       Date:  1997-11-17       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.